Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance (vol 19, 90, 2020) | |
Zhang, Tao1; Qu, Rong1; Chan, Shingpan2; Lai, Mengzhen1,3; Tong, Linjiang1; Feng, Fang1; Chen, Hongyu4; Song, Tingting4; Song, Peiran1; Bai, Gang1,5,6 | |
刊名 | MOLECULAR CANCER |
2021-08-17 | |
卷号 | 20期号:1页码:1 |
DOI | 10.1186/s12943-021-01391-x |
通讯作者 | Ding, Ke(dingke@jnu.edu.cn) ; Ding, Jian(jding@simm.ac.cn) ; Xie, Hua(hxie@simm.ac.cn) |
WOS研究方向 | Biochemistry & Molecular Biology ; Oncology |
语种 | 英语 |
出版者 | BMC |
WOS记录号 | WOS:000686701300001 |
内容类型 | 期刊论文 |
源URL | [http://119.78.100.183/handle/2S10ELR8/297970] |
专题 | 中国科学院上海药物研究所 |
通讯作者 | Ding, Ke; Ding, Jian; Xie, Hua |
作者单位 | 1.Chinese Acad Sci, Shanghai Inst Mat Med, Div Antitumor Pharmacol, State Key Lab Drug Res, 555 Zuchongzhi Rd, Shanghai 201203, Peoples R China 2.Jinan Univ, Guangzhou City Key Lab Precis Chem Drug Dev, Int Cooperat Labo Tradit Chinese Med Modernizat &, Sch Pharm, 601 Huangpu Ave West, Guangzhou 510632, Peoples R China 3.Fudan Univ, Sch Pharm, 826 Zhangheng Rd, Shanghai 201203, Peoples R China 4.Jiangsu Aosaikang Pharmaceut Co Ltd ASK Pharm, 699 Kejian Rd, Nanjing 211112, Peoples R China 5.Univ Chinese Acad Sci, 19A Yuquan Rd, Beijing 100049, Peoples R China 6.Shanghai Tech Univ, Sch Life Sci & Technol, 393 Middle Huaxia Rd, Shanghai 201210, Peoples R China |
推荐引用方式 GB/T 7714 | Zhang, Tao,Qu, Rong,Chan, Shingpan,et al. Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance (vol 19, 90, 2020)[J]. MOLECULAR CANCER,2021,20(1):1. |
APA | Zhang, Tao.,Qu, Rong.,Chan, Shingpan.,Lai, Mengzhen.,Tong, Linjiang.,...&Xie, Hua.(2021).Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance (vol 19, 90, 2020).MOLECULAR CANCER,20(1),1. |
MLA | Zhang, Tao,et al."Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance (vol 19, 90, 2020)".MOLECULAR CANCER 20.1(2021):1. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论